For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
![Harrisburg is taking a wrong approach to drug pricing | PennLive letters](https://cei.org/wp-content/uploads/2024/06/GettyImages-1343695751-578x324-c-default.jpg)
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
![Biden’s got a plan to protect science from Trump](https://cei.org/wp-content/uploads/2024/05/GettyImages-611863118-578x324-c-default.jpg)
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
![New FDA lab tests rule could bankrupt small labs](https://cei.org/wp-content/uploads/2023/07/GettyImages-1293772969-578x324-c-default.jpg)
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
Search Posts
C-SPAN
Video: Senior Fellow Joel Zinberg Joins C-SPAN to Discuss Senate Democratic Health Care and Prescription Drug Proposals
Senior Fellow Joel Zinberg joined the Washington Journal to discuss Senate Democratic Health Care and Prescription Drug Proposals. Click here to read more.
City Journal
No More Masks
Covid-19 cases are on the rise again in the United States. Even President Biden is infected. But the biggest danger is not the virus—the now-dominant…
National Review
Regulators’ Misguided Crackdown on Nicotine Products and Their Makers
Federal agencies must really love black markets. Last week, the Food and Drug Administration (FDA) announced a plan to limit nicotine in cigarettes and …
Blog
The FTC vs. the Right to a Fair Trial
The Food and Drug Administration recently proposed capping the nicotine in cigarettes, which will encourage many smokers to smoke more to get the same nicotine…
Blog
FDA’s Juul Ban Part of Deadly War on Nicotine
The U.S. Food and Drug Administration (FDA) today announced that it denied the application of Juul Labs, maker of the Juul e-cigarette, to market its…
The City Journal
Better Late Than Never?
The federal requirement for a negative Covid-19 test prior to flying into the U.S. and the New York City toddler-mask mandate have both just ended.